Literature DB >> 11396928

Estrogen receptors alpha and beta exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA.

V V Tyulmenkov1, C M Klinge.   

Abstract

Estrogen receptors (ER) alpha and beta bind estradiol (E(2)) and estrogen response element (ERE) DNA sequences with high affinities. The different migration of ER--ERE complexes in the presence or absence of nonspecific DNA suggests that DNA may affect ER conformation and function. We measured the rate of E(2)--ER association and specific ER--ERE binding capacity (ERE--SBC) in the presence or absence of nonspecific DNA. Whereas DNA did not alter the rate of E(2)--ER alpha association, both ERE-containing and plasmid DNA decreased the rate of E(2) association with ER beta. Poly(dI-dC) decreased ERE--SBC of ER alpha, but did not affect the ERE--SBC of ER beta. Salmon sperm genomic DNA decreased the ERE--SBC of ER alpha, but increased the ERE--SBC of ER beta. We speculate that interaction of ER with genomic DNA may contribute to ER activation and play a role in the observed differences in transcriptional activity of ER alpha and ER beta. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11396928     DOI: 10.1006/abbi.2001.2382

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Expanding the paradigm for estrogen receptor binding and transcriptional activation.

Authors:  S R Joshi; R B Ghattamaneni; W M Scovell
Journal:  Mol Endocrinol       Date:  2011-04-28

2.  Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.

Authors:  Fathima R Kona; Karri Stark; Luke Bisoski; Daniela Buac; Qiuzhi Cui; Q Ping Dou
Journal:  Breast Cancer Res Treat       Date:  2012-08-01       Impact factor: 4.872

3.  DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms.

Authors:  Daniel E Frigo; Matthew E Burow; Kamron A Mitchell; Tung-Chin Chiang; John A McLachlan
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

4.  CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.

Authors:  S Sarkar; A Ghosh; S Banerjee; G Maity; A Das; M A Larson; V Gupta; I Haque; O Tawfik; S K Banerjee
Journal:  Oncogenesis       Date:  2017-05-22       Impact factor: 7.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.